在发育和性脑病变中神经调节策略
Debopam Samanta1, Zulfi Haneef2, Gregory W Albert3
1Division of Child Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Epilepsy & behavior : E&B
|October 11, 2024
概括
发育性和性脑病变 (DEE) 是儿童的挑战. 基于网络的神经调节,像深度大脑刺激 (DBS),显示出希望,但需要个性化的方法,以获得更好的结果.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 发育性和性脑病变 (DEE) 是严重的儿童,治疗选择有限.
- 神经调节,包括深度大脑刺激 (DBS) 和响应性神经刺激 (RNS),正在出现耐火DEEs.
- 了解特定综合征的大脑网络对于优化神经调节至关重要.
研究的目的:
- 审查DEE中网络的神经成像发现.
- 探索体DBS在伦诺克斯-加斯托综合征 (LGS) 中的作用,作为基于网络的神经调节的模型.
- 确定未来的研究方向,以提高DEE中神经调节的疗效.
主要方法:
- 对与DEE相关的大脑网络的神经成像研究的综述.
- 检查LGS的中心中位 thalamic DBS 的检查.
- 在各种DEE病因学中分析DBS和RNS应用.
主要成果:
- DEE共享共同的网络参与,包括丘脑和默认模式网络 (DMN).
- 对LGS的thalamic DBS显示了适度的疗效,突出显示了响应的变化.
- 目前用于DEE的神经调节方法的结果各不相同,表明需要改进.
结论:
- 网络洞察力对于优化DEE中神经调节至关重要.
- 需要个性化,基于网络的策略,可能使用LGS作为模型,用于DEE.
- 未来的研究应该集中在个性化连接和生物标志物上,以改善神经调节结果.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
263
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
263
01:24Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
01:14Antiepileptic Drugs: Glutamate Antagonists
287
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
287
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
338
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
338